BLOOD DONATION AS A HEALTH INTERVENTION: BENEFITS, RISKS AND PHYSIOLOGICAL ADAPTATIONS
Abstract
Background: Blood donation, traditionally regarded as a „priceless gift of life” and altruistic act of supporting healthcare systems, has increasingly been examined as a potential health - modifying intervention for donors themselves. This review synthesizes current evidence on the physiological benefits, potential risks and adaptive responses associated with regular blood donation. Health benefits of blood donation include reductions in body iron stores, which can transform into decreased oxidative stress, improved metabolic profiles and lower long - term cardiovascular risk in selected populations. Clinical trials suggests potential modulations in inflammatory markers and improved vascular function following regular donation. However, blood donation is not procedure without risk. There are some acute side effects such as for example vasovagal reactions, temporary weakness and reduced exercise tolerance, while long - term concerns include iron - deficiency anemia, impaired physical performance in high - demand athletes and possible cumulative effects of frequent phlebotomy. Physiological adaptations to recurrent blood loss are for example enhanced erythropoiesis, plasma volume expansion, and changes in iron - regulatory pathways which play a central role in shaping donors’ responses and may differ according to sex, age, nutritional status and donation frequency. By integrating data from clinical trials, epidemiological studies and research this review highlights the complex interplay between the therapeutic potential and physiological cost of blood donation. Understanding these dynamics is crucial for optimizing donor safety, refining eligibility and recovery guidelines and exploring whether periodic blood removal could serve as a targeted intervention in specific clinical or metabolic contexts.
Aim: The aim of this study is to investigate the physiological, metabolic and cardiovascular effects of regular blood donation, in particular donor safety, risk factors and potential health benefits associated with regular blood donation.
Methods: A review of scientific articles published on ResearchGate and PubMed from 1998 to 2025.
Results: Regular blood donation leads to many physiological adaptations, including reduced iron stores, improved lipid profiles, decreased oxidative stress and lower inflammation. Cardiovascular benefits such as for example reduced risk of myocardial infarction have been reported too. Common side effects include vasovagal reactions, temporary hypotension, and, rarely, iron - deficiency anemia in frequent donors. Overall, blood donation can provide health benefits when monitored appropriately.
Conclusion: Blood donation is not only a altruistic act but also a physiological and metabolic intervention. Regular donations are associated with improved cardiovascular and metabolic benefits, reduced oxidative stress and enhanced iron regulation, while side effects remain generally smooth and manageable. With adequate donor screening and monitoring, blood donation can provide significant health benefits, supporting both individual well - being and societal needs for blood supply.
References
Magnussen, K., & Ladelund, S. (2015). Regular blood donation and risk of cardiovascular events: A population-based cohort study. Transfusion, 55(12), 2917–2924.
Duffy, G., et al. (2020). Blood donation as a metabolic intervention: Effects on oxidative stress, inflammation, and lipid metabolism. Clinical Biochemistry, 78, 37–45
Asif, N., et al. (2020). Physiological responses to blood donation: Hemodynamic, hematological, and iron-regulatory adaptations. Journal of Physiology and Biochemistry, 76(4), 543–556
Zheng, G., et al. (2019). Effect of regular blood donation on iron stores and insulin resistance: A systematic review and meta-analysis. Transfusion Medicine Reviews, 33(3), 170–177
Pham, H., et al. (2021). Acute and delayed vasovagal reactions in blood donors: Pathophysiology, risk factors, and prevention strategies. Vox Sanguinis, 116(3), 243–254.
Harrison, G., Rabbitts, J., & Karjalainen, J. (1998). Donation of blood is associated with reduced risk of myocardial infarction: The Kuopio Ischaemic Heart Disease Risk Factor Study. American Journal of Epidemiology, 148(5), 445–451. https://doi.org/10.1093/oxfordjournals.aje.a009669
Zheng, H., Cable, R., Spencer, B., Votto, N., & Katz, S. D. (2005). Iron stores and vascular function in voluntary blood donors. Arteriosclerosis, thrombosis, and vascular biology, 25(8), 1577–1583. https://doi.org/10.1161/01.ATV.0000174126.28201.61
van Jaarsveld, H., & Pool, G. F. (2002). Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein. Atherosclerosis, 161(2), 395–402. https://doi.org/10.1016/s0021-9150(01)00638-4
Yunce, M., Erdamar, H., Bayram, N. A., & Gok, S. (2016). One more health benefit of blood donation: reduces acute-phase reactants, oxidants and increases antioxidant capacity. Journal of basic and clinical physiology and pharmacology, 27(6), 653–657. https://doi.org/10.1515/jbcpp-2015-0111
Quee, F. A., Peffer, K., Ter Braake, A. D., & Van den Hurk, K. (2022). Cardiovascular Benefits for Blood Donors? A Systematic Review. Transfusion medicine reviews, 36(3), 143–151. https://doi.org/10.1016/j.tmrv.2022.04.004
Klein HG. Blood Donor Demographics and Transfusion Recipient Survival—No Country for Old Men? JAMA Intern Med. 2016;176(9):1315–1316. doi:10.1001/jamainternmed.2016.3355
Jóhannsdóttir, V., Gudmundsson, S., Möller, E., Aspelund, T. and Zoëga, H. (2016), Blood donors in Iceland: a nationwide population-based study from 2005 to 2013. Transfusion, 56: 1654-1661. https://doi.org/10.1111/trf.13522
Chassé, M., Fergusson, D. A., Tinmouth, A., Acker, J. P., Perelman, I., Tuttle, A., English, S. W., Hawken, S., Forster, A. J., Shehata, N., Thavorn, K., Wilson, K., Cober, N., Maddison, H., & Tokessy, M. (2023). Effect of Donor Sex on Recipient Mortality in Transfusion. The New England journal of medicine, 388(15), 1386–1395. https://doi.org/10.1056/NEJMoa2211523
Wu, Y., Qi, H., Di Angelantonio, E., Kaptoge, S., Wood, A. M., & Kim, L. G. (2025). Risk factors for vasovagal reactions in blood donors: A systematic review and meta-analysis. Transfusion, 65(1), 211–223. https://doi.org/10.1111/trf.18078
Thijsen, A., & Masser, B. (2019). Vasovagal reactions in blood donors: risks, prevention and management. Transfusion medicine (Oxford, England), 29 Suppl 1, 13–22. https://doi.org/10.1111/tme.12488
Wiersum-Osselton, J. C., Marijt-van der Kreek, T., Brand, A., Veldhuizen, I., van der Bom, J. G., & de Kort, W. (2014). Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return. Blood transfusion = Trasfusione del sangue, 12 Suppl 1(Suppl 1), s28–s36. https://doi.org/10.2450/2013.0262-12
Spencer, B. R., & Mast, A. E. (2022). Iron status of blood donors. Current opinion in hematology, 29(6), 310–316. https://doi.org/10.1097/MOH.0000000000000733
Vassallo R. R. (2019). Donor iron depletion: beneficial or burdensome?. Transfusion, 59(7), 2184–2186. https://doi.org/10.1111/trf.15282
Karregat, J. H. M., Quee, F. A., Twisk, J. W. R., & van den Hurk, K. (2024). Donor knowledge and perceptions regarding donation-induced iron depletion and iron supplementation as a blood service policy. Vox sanguinis, 119(10), 1047–1057. https://doi.org/10.1111/vox.13712
Shander, A., Lobel, G. P., & Javidroozi, M. (2016). Transfusion practices and infectious risks. Expert review of hematology, 9(6), 597–605. https://doi.org/10.1586/17474086.2016.1164593
Khan AI, Goldin J, Gupta G. Noninfectious Complications of Blood Transfusion. [Updated 2025 Mar 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK574536/?utm_source=chatgpt.com
Marik P. E. (2009). The hazards of blood transfusion. British journal of hospital medicine (London, England : 2005), 70(1), 12–15. https://doi.org/10.12968/hmed.2009.70.1.37688
Dasararaju, R., & Marques, M. B. (2015). Adverse effects of transfusion. Cancer control : journal of the Moffitt Cancer Center, 22(1), 16–25. https://doi.org/10.1177/107327481502200104
Ozment, C. P., & Turi, J. L. (2009). Iron overload following red blood cell transfusion and its impact on disease severity. Biochimica et biophysica acta, 1790(7), 694–701. https://doi.org/10.1016/j.bbagen.2008.09.010
Dasararaju, R., & Marques, M. B. (2015). Adverse effects of transfusion. Cancer control : journal of the Moffitt Cancer Center, 22(1), 16–25. https://doi.org/10.1177/107327481502200104
Li, H., Condon, F., Kessler, D., Nandi, V., Rebosa, M., Westerman, M., Shaz, B. H., & Ginzburg, Y. (2016). Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency. Journal of clinical apheresis, 31(6), 551–558. https://doi.org/10.1002/jca.21448
Aardal Eriksson, E., Mobäck, C., Jakobsson, S., & Hoffmann, J. J. (2015). Iron depletion in blood donors - Have extended erythrocyte and reticulocyte parameters diagnostic utility?. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 53(1), 76–81. https://doi.org/10.1016/j.transci.2015.03.011
Zheng, H., Cable, R., Spencer, B., Votto, N., & Katz, S. D. (2005). Iron stores and vascular function in voluntary blood donors. Arteriosclerosis, thrombosis, and vascular biology, 25(8), 1577–1583. https://doi.org/10.1161/01.ATV.0000174126.28201.61
Kurhaluk, N., Gradziuk, M., & Tkaczenko, H. (2024). Optimisation of Blood Donor Nutrition: Blood Donor Health Improvement Studies. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 58(6), 756–806. https://doi.org/10.33594/000000747
Mast, A. E., Foster, T. M., Pinder, H. L., Beczkiewicz, C. A., Bellissimo, D. B., Murphy, A. T., Kovacevic, S., Wroblewski, V. J., & Witcher, D. R. (2008). Behavioral, biochemical, and genetic analysis of iron metabolism in high-intensity blood donors. Transfusion, 48(10), 2197–2204. https://doi.org/10.1111/j.1537-2995.2008.01823.x
Spencer, B. R., & Mast, A. E. (2022). Iron status of blood donors. Current opinion in hematology, 29(6), 310–316. https://doi.org/10.1097/MOH.0000000000000733
Wu, Y., Qi, H., Di Angelantonio, E., Kaptoge, S., Wood, A. M., & Kim, L. G. (2025). Risk factors for vasovagal reactions in blood donors: A systematic review and meta-analysis. Transfusion, 65(1), 211–223. https://doi.org/10.1111/trf.18078
Thijsen, A., & Masser, B. (2019). Vasovagal reactions in blood donors: risks, prevention and management. Transfusion medicine (Oxford, England), 29 Suppl 1, 13–22. https://doi.org/10.1111/tme.12488
Fisher, S. A., Allen, D., Dorée, C., Naylor, J., Di Angelantonio, E., & Roberts, D. J. (2016). Interventions to reduce vasovagal reactions in blood donors: a systematic review and meta-analysis. Transfusion medicine (Oxford, England), 26(1), 15–33. https://doi.org/10.1111/tme.12275
Smith, G. A., Fisher, S. A., Doree, C., Di Angelantonio, E., & Roberts, D. J. (2014). Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. The Cochrane database of systematic reviews, 2014(7), CD009532. https://doi.org/10.1002/14651858.CD009532.pub2
Copyright (c) 2025 Piotr Bartnik, Mikołaj Wiśniewski, Weronika Buczek, Jolanta Wiśniewska, Magdalena Pietrzak, Karolina Barzyk, Urszula Marzec
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
